Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2014 Jan;57(1):30-9.
doi: 10.1007/s00125-013-3058-y. Epub 2013 Sep 25.

HbA1c, fasting and 2 h plasma glucose in current, ex- and never-smokers: a meta-analysis

Collaborators, Affiliations
Meta-Analysis

HbA1c, fasting and 2 h plasma glucose in current, ex- and never-smokers: a meta-analysis

Soraya Soulimane et al. Diabetologia. 2014 Jan.

Abstract

Aims/hypothesis: The relationships between smoking and glycaemic variables have not been well explored. We compared HbA1c, fasting plasma glucose (FPG) and 2 h plasma glucose (2H-PG) in current, ex- and never-smokers.

Methods: This meta-analysis used individual data from 16,886 men and 18,539 women without known diabetes in 12 DETECT-2 consortium studies and in the French Data from an Epidemiological Study on the Insulin Resistance Syndrome (DESIR) and Telecom studies. Means of three glycaemic variables in current, ex- and never-smokers were modelled by linear regression, with study as a random factor. The I (2) statistic was used to evaluate heterogeneity among studies.

Results: HbA1c was 0.10% (95% CI 0.08, 0.12) (1.1 mmol/mol [0.9, 1.3]) higher in current smokers and 0.03% (0.01, 0.05) (0.3 mmol/mol [0.1, 0.5]) higher in ex-smokers, compared with never-smokers. For FPG, there was no significant difference between current and never-smokers (-0.004 mmol/l [-0.03, 0.02]) but FPG was higher in ex-smokers (0.12 mmol/l [0.09, 0.14]). In comparison with never-smokers, 2H-PG was lower (-0.44 mmol/l [-0.52, -0.37]) in current smokers, with no difference for ex-smokers (0.02 mmol/l [-0.06, 0.09]). There was a large and unexplained heterogeneity among studies, with I (2) always above 50%; I (2) was little changed after stratification by sex and adjustment for age and BMI. In this study population, current smokers had a prevalence of diabetes that was 1.30% higher as screened by HbA1c and 0.52% lower as screened by 2H-PG, in comparison with never-smokers.

Conclusion/interpretation: Across this heterogeneous group of studies, current smokers had a higher HbA1c and lower 2H-PG than never-smokers. This will affect the chances of smokers being diagnosed with diabetes.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
(a) Difference in mean (95% CI) HbA1c between current-smokers and never-smokers is 0.10 (0.08,0.12) % [1.1 (0.9,1.3) mmol/mol]; between ex-smokers and never-smokers 0.03 (0.01,0.05) %.[0.3 (0.1,0.5)]. The I2 heterogeneity statistic was 93% and 55% respectively. (b) Difference in mean (95% CI) FPG between current-smokers and never-smokers is −0.004 (−0.06,0.02) mmol/l; between ex-smokers and never-smokers 0.12 (0.09,0.14) mmol/l. The I2 heterogeneity statistic was 71% and 89% respectively. (c) Difference in mean (95% CI) 2H-PG (c) between current-smokers and never-smokers is −0.44 (−0.52,−0.37) mmol/l; between ex-smokers and never-smokers 0.02 (−0.06,0.09) mmol/l. The I2 heterogeneity statistic was 88% and 62% respectively.
Fig. 1
Fig. 1
(a) Difference in mean (95% CI) HbA1c between current-smokers and never-smokers is 0.10 (0.08,0.12) % [1.1 (0.9,1.3) mmol/mol]; between ex-smokers and never-smokers 0.03 (0.01,0.05) %.[0.3 (0.1,0.5)]. The I2 heterogeneity statistic was 93% and 55% respectively. (b) Difference in mean (95% CI) FPG between current-smokers and never-smokers is −0.004 (−0.06,0.02) mmol/l; between ex-smokers and never-smokers 0.12 (0.09,0.14) mmol/l. The I2 heterogeneity statistic was 71% and 89% respectively. (c) Difference in mean (95% CI) 2H-PG (c) between current-smokers and never-smokers is −0.44 (−0.52,−0.37) mmol/l; between ex-smokers and never-smokers 0.02 (−0.06,0.09) mmol/l. The I2 heterogeneity statistic was 88% and 62% respectively.
Fig. 1
Fig. 1
(a) Difference in mean (95% CI) HbA1c between current-smokers and never-smokers is 0.10 (0.08,0.12) % [1.1 (0.9,1.3) mmol/mol]; between ex-smokers and never-smokers 0.03 (0.01,0.05) %.[0.3 (0.1,0.5)]. The I2 heterogeneity statistic was 93% and 55% respectively. (b) Difference in mean (95% CI) FPG between current-smokers and never-smokers is −0.004 (−0.06,0.02) mmol/l; between ex-smokers and never-smokers 0.12 (0.09,0.14) mmol/l. The I2 heterogeneity statistic was 71% and 89% respectively. (c) Difference in mean (95% CI) 2H-PG (c) between current-smokers and never-smokers is −0.44 (−0.52,−0.37) mmol/l; between ex-smokers and never-smokers 0.02 (−0.06,0.09) mmol/l. The I2 heterogeneity statistic was 88% and 62% respectively.

References

    1. Beaglehole R, Bonita R, Horton R, et al. Priority actions for the non-communicable disease crisis. Lancet. 2011;377:1438–1447. - PubMed
    1. Willi C, Bodenmann P, Ghali WA, Faris PD, Cornuz J. Active smoking and the risk of type 2 diabetes: a systematic review and meta-analysis. JAMA. 2007;298:2654–2664. - PubMed
    1. Sicree RA, Zimmet PZ, Dunstan DW, Cameron AJ, Welborn TA, Shaw JE. Differences in height explain gender differences in the response to the oral glucose tolerance test- the AusDiab study. Diabet Med. 1988;25:296–302. - PubMed
    1. DECODE Study Group on behalf of the European Diabetes Epidemiology Study Group Will new diagnostic criteria for diabetes mellitus change phenotype of patients with diabetes? Reanalysis of European epidemiological data. BMJ. 1998;317:371–375. - PMC - PubMed
    1. Simon D, Senan C, Garnier P, Saint-Paul M, Papoz L. Epidemiological features of glycated haemoglobin A1c-distribution in a healthy population. The Telecom Study. Diabetologia. 1989;32:864–869. - PubMed

Publication types

LinkOut - more resources